Correspondence 0001493152-23-037242 from MARIZYME, INC. (MRZM) (CIK 0001413754)

MARIZYME, INC. (MRZM) (CIK 0001413754)
Date: Oct. 13, 2023 · CIK: 0001413754 · Accession: 0001493152-23-037242

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-273308

Date

October 17, 2023

Author

Marizyme

Form

CORRESP

Company

MARIZYME, INC. (MRZM) (CIK 0001413754)

Letter

Washington, DC 20549 Attn: Tim Buchmiller Re: Marizyme, Inc. Registration Statement on Form S-1 (File No. 333-273308)

Dear Mr. Buchmiller:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Marizyme, Inc. hereby respectfully requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) and declare such Registration Statement effective at 5:00 p.m. (Eastern Time) on Tuesday, October 17, 2023, or as soon thereafter as practicable.

It would be appreciated if, as soon as the Registration Statement is declared effective, you would so inform Louis A. Bevilacqua of Bevilacqua PLLC at (202) 869-0888, ext. 100.

Respectfully,
Marizyme,
Inc.

Show Raw Text

CORRESP
1
filename1.htm

Marizyme,
Inc.

555
Heritage Drive, Suite 205

Jupiter,
Florida 33458

October
13, 2023

U.S.
Securities and Exchange Commission

100
F Street, N.E.

Washington,
DC 20549

Attn:
Tim Buchmiller

Re: Marizyme,
                                            Inc.

 Registration
                                            Statement on Form S-1 (File No. 333-273308)

Dear
Mr. Buchmiller:

Pursuant
to Rule 461 under the Securities Act of 1933, as amended, Marizyme, Inc. hereby respectfully requests that the Securities and Exchange
Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”)
and declare such Registration Statement effective at 5:00 p.m. (Eastern Time) on Tuesday, October 17, 2023, or as soon thereafter as
practicable.

It
would be appreciated if, as soon as the Registration Statement is declared effective, you would so inform Louis
A. Bevilacqua of Bevilacqua PLLC at (202) 869-0888, ext. 100.

    Respectfully,

    Marizyme,
    Inc.

    By:
    /s/
    David Barthel

    David
    Barthel

    Chief
    Executive Officer

cc:
Louis A. Bevilacqua, Esq.

SecProbe.io